Cargando…

Selective CB(2) Receptor Agonist, HU-308, Reduces Systemic Inflammation in Endotoxin Model of Pneumonia-Induced Acute Lung Injury

Acute respiratory distress syndrome (ARDS) and sepsis are risk factors contributing to mortality in patients with pneumonia. In ARDS, also termed acute lung injury (ALI), pulmonary immune responses lead to excessive pro-inflammatory cytokine release and aberrant alveolar neutrophil infiltration. Sys...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hall, Stefan, Faridi, Sufyan, Trivedi, Purvi, Sultana, Saki, Ray, Bithika, Myers, Tanya, Euodia, Irene, Vlatten, David, Castonguay, Mathieu, Zhou, Juan, Kelly, Melanie, Lehmann, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779896/ https://www.ncbi.nlm.nih.gov/pubmed/36555499 http://dx.doi.org/10.3390/ijms232415857

Ejemplares similares

Anti-Inflammatory Effects of the Iron Chelator, DIBI, in Experimental Acute Lung Injury
por: Lehmann, Christian, et al.
Publicado: (2022)

HU308 Mitigates Osteoarthritis by Stimulating Sox9‐Related Networks of Carbohydrate Metabolism
por: Carmon, Idan, et al.
Publicado: (2022)

The Use of CBD and Its Synthetic Analog HU308 in HIV-1-Infected Myeloid Cells
por: Williams, Anastasia, et al.
Publicado: (2023)

Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG‐018
por: Finlay, David B., et al.
Publicado: (2022)

The Cannabinoids Δ(8)THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation
por: Thapa, Dinesh, et al.
Publicado: (2018)

Endogenous glucose release in hyperdynamic porcine endotoxin shock: N(G)-monomethyl-L-arginine (L-NMMA) versus noradrenaline
por: Vlatten, A, et al.
Publicado: (1998)

Hepatic O(2) transport and energy balance in hyperdynamic porcine endotoxin shock: N(G)-monornethyl-L-arginine (L-NMMA) versus noradrenaline
por: Rieger, KM, et al.
Publicado: (1998)

Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence
por: Ibsen, Mikkel Søes, et al.
Publicado: (2019)

Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist
por: Polini, Beatrice, et al.
Publicado: (2020)

Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity
por: Franks, Lirit N., et al.
Publicado: (2016)

Evaluation of carboxamide-type synthetic cannabinoids as CB(1)/CB(2) receptor agonists: difference between the enantiomers
por: Doi, Takahiro, et al.
Publicado: (2017)

Time-Dependent Protection of CB2 Receptor Agonist in Stroke
por: Yu, Seong-Jin, et al.
Publicado: (2015)

Distinct Repopulation Activity in Hu-Mice between CB- and LPB-CD34(＋) Cells by Enrichment of Transcription Factors
por: Han, A-Reum, et al.
Publicado: (2021)

Vascular Dysfunction in a Transgenic Model of Alzheimer's Disease: Effects of CB1R and CB2R Cannabinoid Agonists
por: Navarro-Dorado, Jorge, et al.
Publicado: (2016)

Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced Uveitis
por: Porter, Richard Frederick, et al.
Publicado: (2019)

Protective effects of melatonin receptor agonists on endotoxin-induced uveitis in rats
por: Yuksel, Tugba Nurcan, et al.
Publicado: (2023)

Cannabinoid CB1 receptor agonist ACEA alleviates brain ischemia/reperfusion injury via CB1–Drp1 pathway
por: Yang, Shuai, et al.
Publicado: (2020)

Computational Prediction and Biochemical Analyses of New Inverse Agonists for the CB1 Receptor
por: Scott, Caitlin E., et al.
Publicado: (2015)

EVs-mediated delivery of CB2 receptor agonist for Alzheimer's disease therapy
por: Zhu, Yanjing, et al.
Publicado: (2023)

Analgesic effect of a mixed T-type channel inhibitor/CB(2) receptor agonist
por: Gadotti, Vinicius M, et al.
Publicado: (2013)

CB2 Agonist (AM1241) Improving Effect on Ovalbumin-Induced Asthma in Rats
por: Parlar, Ali, et al.
Publicado: (2020)

Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB(2) receptor
por: Patel, Monica, et al.
Publicado: (2023)

Coupling of CB-2 and CB-1
por: Ansaldo
Publicado: (2003)

Cannabigerol Action at Cannabinoid CB(1) and CB(2) Receptors and at CB(1)–CB(2) Heteroreceptor Complexes
por: Navarro, Gemma, et al.
Publicado: (2018)

Adiponectin receptor agonist AdipoRon relieves endotoxin-induced acute hepatitis in mice
por: Xiao, Wen-Ze, et al.
Publicado: (2019)

Effects of the cannabinoid CB(1) agonist ACEA on salicylate ototoxicity, hyperacusis and tinnitus in guinea pigs
por: Berger, Joel I., et al.
Publicado: (2017)

Anti-inflammatory and antinociceptive effects of the selective cannabinoid CB(2) receptor agonist ABK5
por: Tang, Yaliang, et al.
Publicado: (2020)

Characterization of Subtype Selective Cannabinoid CB(2) Receptor Agonists as Potential Anti-Inflammatory Agents
por: Tang, Yaliang, et al.
Publicado: (2021)

FLUID PHASE DESTRUCTION OF C2(hu) BY C1(hu) : II. UNMASKING BY C4i(hu)OF C1(hu) SPECIFICITY FOR C2(hu)
por: Gigli, Irma, et al.
Publicado: (1969)

HuB and HuD repress telomerase activity by dissociating HuR from TERC
por: Cheng, Xiaolei, et al.
Publicado: (2021)

The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone‐Induced Central Nervous System Demyelination
por: Tomas‐Roig, Jordi, et al.
Publicado: (2016)

Primary Macrophage Chemotaxis Induced by Cannabinoid Receptor 2 Agonists Occurs Independently of the CB(2) Receptor
por: Taylor, Lewis, et al.
Publicado: (2015)

Anti-Obesity Effect of the CB2 Receptor Agonist JWH-015 in Diet-Induced Obese Mice
por: Verty, A. N. A., et al.
Publicado: (2015)

CB(1) Allosteric Modulator Org27569 Is an Antagonist/Inverse Agonist of ERK1/2 Signaling
por: Gamage, Thomas F., et al.
Publicado: (2016)

Modified Alginate-Based Hydrogel as a Carrier of the CB2 Agonist JWH133 for Bone Engineering
por: Zhou, Wei, et al.
Publicado: (2021)

Effects of a CB(2) Subtype Selective Agonist ABK5-1 on Cytokine Production in Microglia
por: Tang, Yaliang, et al.
Publicado: (2021)

Discovery of Potent and Selective CB2 Agonists Utilizing a Function-Based Computational Screening Protocol
por: Ge, Haixia, et al.
Publicado: (2023)

A prospective randomized half-body study: 308 nm LED light vs. 308 nm excimer laser for localized psoriasis
por: Yu, Yingyuan, et al.
Publicado: (2023)

Treatment of Diet-Induced Obese Rats with CB(2) Agonist AM1241 or CB(2) Antagonist AM630 Reduces Leptin and Alters Thermogenic mRNA in Adipose Tissue
por: O’Keefe, Lannie, et al.
Publicado: (2023)

CB0 is finished machining, and for CB+1 the shell is finished.
por: P. Fabbricatore
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_fooruuj98e2qb2jt9tuk5uceim